Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -5.74% is 88% above its 5-year average of -48.19%, near the high end of its 5-year range (-118.74%–1.32%).
18.94% above its 12-month average of -7.08%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -9.95%.
EBITDA MARGIN
-5.74%
EBITDA MARGIN AVG TTM
-7.08%
EBITDA MARGIN AVG 3Y
-17.10%
EBITDA MARGIN AVG 5Y
-48.19%
EBITDA MARGIN AVG 10Y
-63.26%
EBITDA MARGIN AVG 15Y
-100.36%
EBITDA MARGIN AVG 20Y
-168.37%
CURRENT VS TTM AVG
+18.94%
CURRENT VS 3Y AVG
+66.43%
CURRENT VS 5Y AVG
+88.09%
CURRENT VS 10Y AVG
+90.93%
CURRENT VS 15Y AVG
+94.28%
CURRENT VS 20Y AVG
+96.59%
MDxHealth S.A.
Market Cap
$29.99M
EBITDA Margin
-5.74%
TTM Avg
-7.08%
3Y Avg
-17.10%
5Y Avg
-48.19%
Market Cap
$29.96M
EBITDA Margin
-2671.72%
TTM Avg
-3785.12%
3Y Avg
-14400.08%
5Y Avg
-14400.08%
Market Cap
$29.88M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
Market Cap
$30.23M
EBITDA Margin
-10097.04%
TTM Avg
-6618.17%
3Y Avg
-8743.58%
5Y Avg
-8072.84%
Market Cap
$29.70M
EBITDA Margin
-706.55%
TTM Avg
-1095.73%
3Y Avg
-881.72%
5Y Avg
-688.00%
Market Cap
$29.60M
EBITDA Margin
-2299.40%
TTM Avg
-2138.43%
3Y Avg
-3018.63%
5Y Avg
-2749.35%
Market Cap
$30.94M
EBITDA Margin
-76.51%
TTM Avg
-510.64%
3Y Avg
-659.38%
5Y Avg
-619.37%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $29.99M | -5.74% | -7.08% | -17.10% | -48.19% |
| BeyondSpring Inc. (BYSI)vs › | $29.96M | -2671.72% | -3785.12% | -14400.08% | -14400.08% |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| CervoMed Inc. (CRVO)vs › | $30.23M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
| OneMedNet Corporation (ONMD)vs › | $29.70M | -706.55% | -1095.73% | -881.72% | -688.00% |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -2299.40% | -2138.43% | -3018.63% | -2749.35% |
| Context Therapeutics Inc. (CNTX)vs › | $29.41M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.69M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.94M | -76.51% | -510.64% | -659.38% | -619.37% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.14% | 1.67% | 3.35% | 2.87% |
Gross Margin
59.7%
EBITDA Margin
-5.7%
Operating Margin
-14.3%
Net Margin
-31.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -9.95% |
| 2025-12-31 | -12.61% |
| 2025-06-30 | 1.32% |
| 2024-12-31 | -13.23% |
| 2024-06-30 | -24.59% |
| 2023-12-31 | -19.15% |
| 2023-06-30 | -41.49% |
| 2022-12-31 | -72.96% |
| 2022-06-30 | -118.74% |
| 2021-12-31 | -111.89% |
| 2021-06-30 | -106.79% |
| 2020-12-31 | -140.25% |
| 2020-06-30 | -114.50% |
| 2019-12-31 | -2680.59% |
| 2019-06-30 | -111.85% |
| 2018-12-31 | -139.85% |
| 2018-06-30 | -78.33% |
| 2017-12-31 | -78.39% |
| 2017-06-30 | 5.91% |
| 2016-12-31 | -26.00% |
| 2016-06-30 | -51.75% |
| 2015-12-31 | -86.96% |
| 2015-06-30 | -67.14% |
| 2014-12-31 | -103.10% |
| 2014-06-30 | -165.13% |
| 2013-12-31 | -225.04% |
| 2013-06-30 | -189.73% |
| 2012-12-31 | -172.92% |
| 2012-06-30 | -223.42% |
| 2011-12-31 | -256.16% |
| 2011-06-30 | -256.16% |
| 2010-12-31 | -321.14% |
| 2010-06-30 | -321.14% |
| 2009-12-31 | -560.48% |
| 2009-06-30 | -560.48% |
| 2008-12-31 | -336.74% |
| 2008-06-30 | -336.74% |
| 2007-12-31 | -377.70% |
| 2007-06-30 | -377.70% |
| 2006-12-31 | -265.90% |
| 2006-06-30 | -265.90% |
| 2005-12-31 | -138.98% |
| 2005-06-30 | -138.98% |
| 2004-12-31 | -1338.66% |
| 2004-06-30 | -1338.66% |
